Non-steroidal Anti-inflammatory Drugs (NSAID) Market Strategies and Forecast by 2031

MARKET INTRODUCTION

The non-steroidal anti-inflammatory drugs are a type of pain reliever that help to reduce inflammation and lower fevers. The NSAIDs are the most prescribed medications, which are used to treat conditions that cause pain or inflammation, such as arthritis. The non-steroidal anti-inflammatory drugs such as, aspirin and ibuprofen, are considered as the first line of treatment in pain management due to three basic properties: analgesic, antipyretic, and anti-inflammatory.

MARKET DYNAMICS

The non-steroidal anti-inflammatory drugs (NSAID) market is anticipated to grow due to rising prevalence of bone & joint disorders such as rheumatoid arthritis & osteoarthritis, and rising incidence of pain disorders and increase in geriatric population with high risk of various diseases across the globe. However, increase in number of hospital surgeries and growing adoption of pain management therapeutics are likely to grow the market during the forecast period.

MARKET SCOPE

The "Global Non-Steroidal Anti-Inflammatory Drugs (NSAID) Market Analysis to 2031" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of non-steroidal anti-inflammatory drugs (NSAID) market with detailed market segmentation by dosage form, indication, end user and geography. The global non-steroidal anti-inflammatory drugs (NSAID) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading non-steroidal anti-inflammatory drugs (NSAID) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global non-steroidal anti-inflammatory drugs (NSAID) market is segmented on the basis of dosage form, indication, and end user. On the basis of dosage form, oral, topical and injectable. Based on indication, the market is classified as, postoperative pain, bone & joint pain, sports injuries, menstruation and others. The non-steroidal anti-inflammatory drugs (NSAID) market, on the basis of end user is categorized as, hospital pharmacies, retail pharmacies and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global non-steroidal anti-inflammatory drugs (NSAID) market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The non-steroidal anti-inflammatory drugs (NSAID) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting non-steroidal anti-inflammatory drugs (NSAID) market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the non-steroidal anti-inflammatory drugs (NSAID) market in these regions.

MARKET PLAYERS

The reports cover key developments in the non-steroidal anti-inflammatory drugs (NSAID) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from non-steroidal anti-inflammatory drugs (NSAID) market are anticipated to lucrative growth opportunities in the future with the rising demand for non-steroidal anti-inflammatory drugs (NSAID) market in the global market. Below mentioned is the list of few companies engaged in the non-steroidal anti-inflammatory drugs (NSAID) market.

The report also includes the profiles of key non-steroidal anti-inflammatory drugs (NSAID) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Pfizer Inc.
• Reckitt Benckiser Group plc.
• Novartis AG
• Bayer AG
• DAIICHI SANKYO COMPANY, LIMITED.
• AbbVie Inc.
• GlaxoSmithKline plc.
• Merck & Co., Inc.
• Eli Lilly and Company
• AstraZeneca

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Non-steroidal Anti-inflammatory Drugs (NSAID) Report Scope